300
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2028
Study Completion Date
December 31, 2028
Thoracic Radiotherapy 45 Gy BID
45 Gy delivered in 30 fractions of 1.5 Gy twice daily over three weeks, with 95% of the planning target volume (PTV) receiving at least 95% of the prescribed dose.
Thoracic Radiotherapy 60 Gy BID
60 Gy delivered in 40 fractions of 1.5 Gy BID. A minimum dose of 54 Gy will be accepted if organ-at-risk tolerance is exceeded.
Thoracic Radiotherapy SIB 45-54 Gy BID
45 Gy in 30 fractions (1.5 Gy BID) to PTV and 54 Gy in 30 fractions (1.8 Gy BID) to high-risk CTV. Both delivered simultaneously using 3D conformal planning.
Complejo Asistencial Universitario de Salamanca, Salamanca
Hospital Universitario de Torrecardenas, Almería
Hospital Universitario de Cruces, Barakaldo
Instituto Catalán de Oncología, Girona
Hospital Dr. Negrin, Las Palmas de Gran Canaria
Hospital Gregorio Marañon, Madrid
Hospital Ramon y Cajal, Madrid
Hospital Universitario Virgen de Arrixaca, Murcia
Hospital Marques de Valdecilla, Santander
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
Genesis Care, Seville
Hospital Universitario Virgen del Rocio, Seville
Hospital La Fe, Valencia
Spanish Lung Cancer Group
OTHER
Instituto de Investigación Biomédica de Salamanca
OTHER